Anterior Cutaneus Nerve and Distal Adductor Canal Block With USG for Total Knee Replacement Analgesia

Not Applicable

Completed

• Conditions: Nerve Block; Pain Measurement; Knee Replacement Arthroplasty
• Interventions: Procedure: Adductor canal blockade; Procedure: Distal adductor canala blockade and anterior cutaneus nerve blockade

• Registration Number: NCT06201195
• Lead Sponsor: Diskapi Teaching and Research Hospital

Brief Summary

The goal of this clinical trial is to compare analhesia effects of adductor canal blockade versus distal adductur canal blockade added anterior cutaneus nerve block in total knee arthroplasty.

The main questions it aims to answer are:

* question 1: does distal adductor canal blockade + anterior cutaneus nerve blokade superior analgesia then adductor canal block for undergoing TKP?

* question 2: does distal adductor canal blockade + anterior cutaneus nerve blokade decrease drain place pain on anterolateral face of knee?

Detailed Description

Patients with American Society of Anesthesiologists classification status I-III scheduled for elective primary TKA using standard spinal anesthesia enroll for this trial. After surgery patient divided two groups: 1- adductor canal blockade 2- distal adductor canal blockade + anterior femoral cutaneus nerve blockade. At postoperative 3th, 10th, 24th hour VAS (visuel analouge scale), VAS move, incision plase pain-for top and down of patella, drain place pain, motor strenght for femoral nerve and siyatic nerve, first analjesic requirement time, opioid consumption, total analcesic requirement will be recorded.

Study Timeline

• Study Start: 2023-10-01
• Study First Submitted: 2023-10-25
• Study First Submitted QC: 2023-12-29
• Study First Posted: 2024-01-11
• Primary Completion: 2024-01-25
• Study Completion: 2024-02-01
• Status Verified: 2024-06
• Last Update Submitted: 2024-06-05
• Last Update Posted: 2024-06-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 58

Inclusion Criteria

• Total knee artroplasty
• Spinal anesthesia
• ASA 1-3

Exclusion Criteria

• Bupivacaine allergy
• Coagulopathy
• Infection on injection site

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Adductor canal block	Adductor canal blockade	Usg guidance adductor canal block with %0.25 Bupivacaine 20 ml
Distal adductor canal block with anterior cutaneus nerve block	Distal adductor canala blockade and anterior cutaneus nerve blockade	Usg guidance distal adductor canal block (%0.25 Bupivacaine 20 ml) with anterior cutaneus nerve block (%0.25 Bupivacaine 10 ml)

Primary Outcome Measures

Name	Time	Method
drain place pain	postblock 3 hour,10 hour, 24 hour	do you have any pain on drain place? yes or no
VAS (visuel analouge scale)	postblock 3 hour,10 hour, 24 hour	for postoperative pain evaluation after TKA surgery. The visual analogue scale (VAS) uses a 10 cm line with endpoint descriptors such as 'no pain' marked at the left end of the line and 'worst pain imaginable' marked at the right end.

Secondary Outcome Measures

Name	Time	Method
motor strenght	postblock 3 hour,10 hour, 24 hour	leg elevation and plantar flexion
VAS movement	postblock 3 hour,10 hour, 24 hour	Postoperative pain with knee moves evaluate with VAS, The visual analogue scale (VAS) uses a 10 cm line with endpoint descriptors such as 'no pain' marked at the left end of the line and 'worst pain imaginable' marked at the right end.

Trial Locations

Locations (1)

Ankara Etlik City Hospital; 🇹🇷 Ankara, Turkey